Ignite Creation Date:
2025-12-25 @ 4:13 AM
Ignite Modification Date:
2026-04-13 @ 4:59 PM
Study NCT ID:
NCT02838420
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-01
First Post:
2016-07-18
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate and Compare the Efficacy and Safety of Alectinib Versus Crizotinib and to Evaluate the Pharmacokinetics of Alectinib in Asian Participants With Treatment-Naive Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-08-03
Start Date Type:
ACTUAL
Primary Completion Date:
2018-05-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2016-07-18
First Submit QC Date:
None
Study First Post Date:
2016-07-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-05-29
Results First Submit QC Date:
None
Results First Post Date:
2019-07-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-17
Last Update Post Date:
2025-10-01
Last Update Post Date Type:
ESTIMATED